一般演題3-7A 多発性骨髄腫：ダラツムマブ

[OS3-7A-6] Daratumumab (DARA) subcutaneous (SC) vs intravenous (IV) administration in pts with RRMM: COLUMBA

Nizar J. Bahlis¹, Maria-Victoria Mateos², Hareth Nahi³, Wojciech Legiec⁴, Vladimir Vorobyev⁵, Ivan Spicka⁶, Vania Hungria⁷, Sibirina Korenkova⁸, Max Flogegard⁹, Joan Blade¹⁰, Philippe Moreau¹¹, Martin Kaiser¹², Shinsuke Iida¹³, Jacob Laubach¹⁴, Tahamtan Ahmadi¹⁵, Pamela L. Clemens¹⁶, Tara Masterson¹⁶, Kristen Lantz¹⁶, Lisa O‘Rourke¹⁶, Christoph Heuck¹⁶, Lixian Peng¹⁷, Dolly A. Parasrampuria¹⁶, Zhilong Yuan¹⁷, Ming Qi¹⁶, Saad Z. Usmani¹⁸ (1.University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada, 2.University Hospital of Salamanca/IBSAL, Salamanca, Spain, 3.Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Kingdom of Sweden, 4.Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Republic of Poland, 5.S.P. Botkin City Clinical Hospital, Moscow, Russian Federation, 6.General Faculty Hospital, Prague, Czech Republic, 7.Clinica São Germano, São Paulo, Federative Republic of Brazil, 8.Kiev Center for Bone Marrow Transplantation, Kiev, Ukraine, 9.Department of Internal Medicine, Falun General Hospital, Falun, Kingdom of Sweden, 10.IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, 11.University Hospital of Nantes, Nantes, France Metropolitan, 12.Division of Molecular Pathology, Institute of Cancer Research, Sutton, United Kingdom of Great Britain and Northern Ireland, 13.Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan, 14.Department of Hematology and Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America, 15.Genmab US, Inc., Princeton, NJ, United States of America, 16.Janssen Research & Development, LLC, Spring House, PA, United States of America, 17.Janssen Research & Development, LLC, Raritan, NJ, United States of America, 18.Levine Cancer Institute/Atrium Health, Charlotte, NC, United States of America)